Botanical species · safety record

Crataegus azarolus

The EFSA Compendium of Botanicals holds 2 constituent measurements for Crataegus azarolus. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Crataegus azarolus L.

2Constituent measurements
0Safety records
2Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Melatonin1
  • Proanthocyanidins (condensed tannins)1

Plant parts

  • Fruit unspecified1
  • Leaves1

Preparations

  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
MelatoninLeavesSolvent extraction435 Picogram/gramEnzyme-linked immunosorbent assay (ELISA)No resolvable identifier
Proanthocyanidins (condensed tannins)Fruit unspecifiedSolvent extraction109 Milligram-equivalent/gramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Hadjira, Abdessemed., Leila, Hambaba., Mohamed, Abdeddaim., Cherif, Aberkane M. Dosage of secondary metabolites of extracts of fruit of Crataegus azarolus L.. Tunisian journal of medicinal plants and natural products, 2011, p. 54-63.
  2. Zohar, Ram., Izhaki, Ido., Koplovich, Avi., Ben-Shlomo, Rachel. Phytomelatonin in the leaves and fruits of wild perennial plants. Phytochemistry Letters, 2011, p. 222-226.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue